share_log

Pfizer | SC TO-C: Written communication relating to an issuer or third party tender offer

Pfizer | SC TO-C: Written communication relating to an issuer or third party tender offer

辉瑞 | SC TO-C:投标报价书面通信
美股SEC公告 ·  08/01 06:08
Moomoo AI 已提取核心信息
Pfizer Inc. has announced a voluntary Modification Offer for eligible employees holding certain equity awards, specifically the Five-Year Total Shareholder Return Units (TSRUs) and Performance Share Awards (PSAs) granted in 2022 and 2023. The offer, which is not yet commenced, aims to modify these awards to enhance their retention and motivational value in light of the company's stock price decline post-COVID-19 pandemic highs. The modification includes extending the performance and vesting periods by two years, among other changes. Eligible participants will have from August 12, 2024, to September 12, 2024, to accept the offer, with the ability to change their election until the expiration time. Pfizer plans to file a Tender Offer Statement with the SEC and will provide the Modification Offer and related materials through the Fidelity NetBenefits online portal, the company's website, and the SEC's website. The company encourages eligible employees to consult with their tax and financial advisors before participating in the offer.
Pfizer Inc. has announced a voluntary Modification Offer for eligible employees holding certain equity awards, specifically the Five-Year Total Shareholder Return Units (TSRUs) and Performance Share Awards (PSAs) granted in 2022 and 2023. The offer, which is not yet commenced, aims to modify these awards to enhance their retention and motivational value in light of the company's stock price decline post-COVID-19 pandemic highs. The modification includes extending the performance and vesting periods by two years, among other changes. Eligible participants will have from August 12, 2024, to September 12, 2024, to accept the offer, with the ability to change their election until the expiration time. Pfizer plans to file a Tender Offer Statement with the SEC and will provide the Modification Offer and related materials through the Fidelity NetBenefits online portal, the company's website, and the SEC's website. The company encourages eligible employees to consult with their tax and financial advisors before participating in the offer.
辉瑞公司已宣布为符合条件的员工提供自愿修改计划,特别针对2022年和2023年授予的五年总股东回报单位(TSRUs)和绩效股票(PSAs)。该计划尚未启动,旨在修改这些奖励以增强其保留和激励价值,以应对COVID-19大流行后公司股价下降的情况。修改内容包括将绩效和归属期延长两年,以及其他变更。符合条件的参与者将有从2024年8月12日至2024年9月12日接受此优惠的时间,并有权在到期前更改他们的选择。辉瑞计划向美国证监会提交招标要约书,并通过富达净利益在线门户、公司网站和美国证监会网站提供修改优惠和相关材料。公司鼓励符合条件的员工在参加优惠计划前咨询他们的税务和财务顾问。
辉瑞公司已宣布为符合条件的员工提供自愿修改计划,特别针对2022年和2023年授予的五年总股东回报单位(TSRUs)和绩效股票(PSAs)。该计划尚未启动,旨在修改这些奖励以增强其保留和激励价值,以应对COVID-19大流行后公司股价下降的情况。修改内容包括将绩效和归属期延长两年,以及其他变更。符合条件的参与者将有从2024年8月12日至2024年9月12日接受此优惠的时间,并有权在到期前更改他们的选择。辉瑞计划向美国证监会提交招标要约书,并通过富达净利益在线门户、公司网站和美国证监会网站提供修改优惠和相关材料。公司鼓励符合条件的员工在参加优惠计划前咨询他们的税务和财务顾问。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息